Immunocore Holdings IMCR
NASDAQ IMCR
$30.29 -0.56 (-1.82%)
At close: Sep 30, 2026 · 4:00 PM EDT

Immunocore Holdings (IMCR) Short term Debt (2019 - 2024)

Updated

Immunocore Holdings (IMCR) posted Short term Debt of $48.21 million for Q3 2024.

Analysis

Immunocore Holdings (IMCR) Short term Debt (2019 - 2024) Analysis & Trends

At the end of FY2019, Immunocore Holdings' Short term Debt came in at $24.63 million.

  • The Q3 2024 figure stands as the lowest quarterly Short term Debt since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Immunocore Holdings 1.59 Bn -1.89 Bn 114.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 48.21 Mn
Dec 31, 2019 24.63 Mn
API Access

Immunocore Holdings Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=IMCR&period=max&api_key=YOUR_API_KEY